(202) 599-8435

Mandating ADFs for Canadian Prescription Opioids Could Reduce Societal Costs

The Canadian Health Policy Institute (CHPI) has published a study which estimates that if all prescription opioids in Canada were abuse deterrent formulations (ADFs), societal costs in the form of the economic value of the health, as well as social and productivity losses associated with the opioid abuse, could be reduced. The study reported that ADFs would discourage non-medical use of opioids, further reducing associated societal costs by an estimated range of savings between $140 million and $4 billion annually. Read more here.

Print Friendly, PDF & Email
About the Author